1. Home
  2. ALKS vs WEX Comparison

ALKS vs WEX Comparison

Compare ALKS & WEX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ALKS
  • WEX
  • Stock Information
  • Founded
  • ALKS 1987
  • WEX 1983
  • Country
  • ALKS Ireland
  • WEX United States
  • Employees
  • ALKS N/A
  • WEX N/A
  • Industry
  • ALKS Biotechnology: Pharmaceutical Preparations
  • WEX Business Services
  • Sector
  • ALKS Health Care
  • WEX Consumer Discretionary
  • Exchange
  • ALKS Nasdaq
  • WEX Nasdaq
  • Market Cap
  • ALKS 5.1B
  • WEX 5.8B
  • IPO Year
  • ALKS 1991
  • WEX 2005
  • Fundamental
  • Price
  • ALKS $29.94
  • WEX $171.26
  • Analyst Decision
  • ALKS Strong Buy
  • WEX Hold
  • Analyst Count
  • ALKS 14
  • WEX 13
  • Target Price
  • ALKS $40.64
  • WEX $179.82
  • AVG Volume (30 Days)
  • ALKS 1.4M
  • WEX 324.9K
  • Earning Date
  • ALKS 10-23-2025
  • WEX 10-23-2025
  • Dividend Yield
  • ALKS N/A
  • WEX N/A
  • EPS Growth
  • ALKS 21.99
  • WEX 37.64
  • EPS
  • ALKS 2.08
  • WEX 7.93
  • Revenue
  • ALKS $1,505,296,000.00
  • WEX $2,598,200,000.00
  • Revenue This Year
  • ALKS N/A
  • WEX $1.02
  • Revenue Next Year
  • ALKS $1.66
  • WEX $5.27
  • P/E Ratio
  • ALKS $14.40
  • WEX $21.48
  • Revenue Growth
  • ALKS N/A
  • WEX N/A
  • 52 Week Low
  • ALKS $25.56
  • WEX $110.45
  • 52 Week High
  • ALKS $36.45
  • WEX $217.47
  • Technical
  • Relative Strength Index (RSI)
  • ALKS 59.07
  • WEX 53.79
  • Support Level
  • ALKS $28.77
  • WEX $165.54
  • Resistance Level
  • ALKS $31.69
  • WEX $173.61
  • Average True Range (ATR)
  • ALKS 0.85
  • WEX 3.55
  • MACD
  • ALKS 0.11
  • WEX -0.73
  • Stochastic Oscillator
  • ALKS 51.25
  • WEX 60.27

About ALKS Alkermes plc

Alkermes PLC is a fully integrated biotechnology company that applies its proprietary technologies to research, develop, and commercialize pharmaceutical products designed for unmet medical needs in therapeutic areas. The company utilizes several to develop and commercialize products and, in so doing, access technological, financial, marketing, manufacturing, and other resources. Alkermes either purchases active drug products from third parties or receives them from its third-party licensees to formulate products using its technologies. It operates in U.S., which derives maximum revenue, Ireland and Rest of the world.

About WEX WEX Inc. common stock

WEX Inc is a provider of corporate payment solutions. The company operates three business segments: Mobility, Benefits, and Corporate Payments. Mobility segment, the top segment by revenue, provides fleet vehicle payment solutions, transaction processing, and information management services for commercial and government fleets. The Corporate Payments segment offers business-to-business payment processing and transaction monitoring services. The Benefits segment generates revenue from healthcare payment products and its consumer-directed software platform. The company's prime end market is the United States of America.

Share on Social Networks: